Royal Bank of Canada’s DexCom DXCM Stock Holding History

Royal Bank of Canada’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.88M	Sell	30,000 -150,000	-83%	-$10.4M	﹤0.01%	3138
2025 Q4	$11.9M	Sell	180,000 -60,000	-25%	-$3.88M	﹤0.01%	1820
2025 Q3	$16.1M	Buy	240,000 +60,000	+33%	+$4.75M	﹤0.01%	1817
2025 Q2	$15.7M	Buy	180,000 +45,000	+33%	+$3.53M	﹤0.01%	1703
2025 Q1	$9.22M	Buy	135,000 +134,800	+67,400%	+$11M	﹤0.01%	1799
2024 Q4	$16K	Hold	200	–	–	﹤0.01%	6192
2024 Q3	$13K	Sell	200 -50,000	-100%	-$4.11M	﹤0.01%	6250
2024 Q2	$5.69M	Buy	+50,200	New	+$6.35M	﹤0.01%	2078
2024 Q1	–	Sell	-20,000	Closed	-$2.48M	–	7139
2023 Q4	$2.48M	Buy	+20,000	New	+$2.04M	﹤0.01%	2879
2017 Q2	–	Sell	-80,000	Closed	-$1.7M	–	6600
2017 Q1	$1.7M	Buy	+80,000	New	+$1.56M	﹤0.01%	2672
2016 Q3	–	Sell	-75,600	Closed	-$1.5M	–	6426
2016 Q2	$1.5M	Hold	75,600	–	–	﹤0.01%	2774
2016 Q1	$1.28M	Buy	+75,600	New	+$1.26M	﹤0.01%	2840
2015 Q3	–	Sell	-80,000	Closed	-$1.6M	–	6666
2015 Q2	$1.6M	Buy	+80,000	New	+$1.41M	﹤0.01%	2506

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Royal Bank of Canada's DXCM Position: Q1 2026 in Review

Royal Bank of Canada reduced its DexCom (DXCM) stake by 22% in Q1 2026, selling an estimated $39.4M and leaving 1,974,424 shares worth $124M. The position accounts for 0.02% of the portfolio, ranked #568.

Royal Bank of Canada first reported a position in DXCM in Q2 2013 and has held it in 52 quarters since. The position peaked at $213M in Q3 2025. 959 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

Royal Bank of Canada held 1,974,424 shares of DexCom worth $124M as of Q1 2026.
Royal Bank of Canada sold 565,324 DexCom shares in Q1 2026, an estimated $39.4M.
DexCom made up 0.02% of Royal Bank of Canada's portfolio in Q1 2026, its #568 holding.
Royal Bank of Canada first reported a position in DexCom in Q2 2013 and has held it in 52 quarters since.
Royal Bank of Canada's DexCom position peaked at $213M in Q3 2025.
959 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.